Does LEFLUNOMIDE Cause Bladder transitional cell carcinoma? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Bladder transitional cell carcinoma have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.0% of all adverse event reports for LEFLUNOMIDE.
11
Reports of Bladder transitional cell carcinoma with LEFLUNOMIDE
0.0%
of all LEFLUNOMIDE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From LEFLUNOMIDE?
Of the 11 reports, 6 (54.5%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does LEFLUNOMIDE Cause?
Drug ineffective (31,396)
Rheumatoid arthritis (20,886)
Pain (15,594)
Drug intolerance (14,142)
Joint swelling (13,026)
Fatigue (11,959)
Arthralgia (11,880)
Rash (11,239)
Contraindicated product administered (11,206)
Abdominal discomfort (10,333)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which LEFLUNOMIDE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
LEFLUNOMIDE vs LEMBOREXANT
LEFLUNOMIDE vs LENACAPAVIR
LEFLUNOMIDE vs LENALIDOMIDE
LEFLUNOMIDE vs LENIOLISIB
LEFLUNOMIDE vs LENOGRASTIM